dc.contributorMu�oz-Valle, J.F., Instituto de Investigaci�n en Reumatolog�a y del Sistema M�sculo Esqueletico, Departamento de Biolog�a Molecular y Gen�mica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico; Valle, Y., Instituto de Investigaci�n en Reumatolog�a y del Sistema M�sculo Esqueletico, Departamento de Biolog�a Molecular y Gen�mica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico; Padilla-Guti�rrez, J.R., Instituto de Investigaci�n en Reumatolog�a y del Sistema M�sculo Esqueletico, Departamento de Biolog�a Molecular y Gen�mica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico; Parra-Rojas, I., Unidad Acad�mica de Ciencias Qu�mico-Biol�gicas, Universidad Aut�noma de Guerrero, Mexico; Rangel-Villalobos, H., Instituto de Investigaci�n en Gen�tica Molecular, Centro Universitario de la Cienega, Universidad de Guadalajara, Ocotl�n, Jalisco, Mexico; del Mercado, M.V., Instituto de Investigaci�n en Reumatolog�a y del Sistema M�sculo Esqueletico, Departamento de Biolog�a Molecular y Gen�mica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico, Departamento de Reumatolog�a, Divisi�n de Medicina Interna. Hospital Civil Dr. Juan I Menchaca, Guadalajara, Jalisco, Mexico; Ledezma-Lozano, I.Y., Instituto de Investigaci�n en Reumatolog�a y del Sistema M�sculo Esqueletico, Departamento de Biolog�a Molecular y Gen�mica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico; Villafan-Bernal, J.R., Instituto de Investigaci�n en Reumatolog�a y del Sistema M�sculo Esqueletico, Departamento de Biolog�a Molecular y Gen�mica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico; Armend�riz-Borunda, J., Instituto de Biolog�a Molecular y Terapia G�nica, CUCS, Universidad de Guadalajara, Mexico; Pereira-Su�rez, A.L., Laboratorio de Inmunolog�a, CUCS, U de G, Mexico
dc.creatorMunoz-Valle, J.F.
dc.creatorValle, Y.
dc.creatorPadilla-Gutierrez, J.R.
dc.creatorParra-Rojas, I.
dc.creatorRangel-Villalobos, H.
dc.creatordel Mercado, M.V.
dc.creatorLedezma-Lozano, I.Y.
dc.creatorVillafan-Bernal, J.R.
dc.creatorArmendariz-Borunda, J.
dc.creatorPereira-Suarez, A.L.
dc.date.accessioned2015-09-15T19:05:20Z
dc.date.accessioned2023-07-03T22:29:51Z
dc.date.available2015-09-15T19:05:20Z
dc.date.available2023-07-03T22:29:51Z
dc.date.created2015-09-15T19:05:20Z
dc.date.issued2010
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-77950461421&partnerID=40&md5=7955880c8a9b83c18b2bcb766503edcd
dc.identifierhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=med5&AN=20138855
dc.identifierhttp://hdl.handle.net/20.500.12104/45014
dc.identifier10.1016/j.cca.2010.02.001
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/7245625
dc.description.abstractBackground: The Cytotoxic T lymphocyte antigen (CTLA-4) is one of the major susceptibility genes associated with autoimmune diseases. Susceptibility to rheumatoid arthritis (RA) is determined by both environmental and genetic factors. The genetic contribution approaches 50-60%. The association between RA with the +. 49A>G CTLA-4 polymorphism in the Mexican population was investigated. Methods: The polymerase chain reaction-restriction fragment was used to amplify the +. 49A>G CTLA-4 polymorphism in RA patients and healthy subjects (HS). Results: We analyzed the association between the +. 49A>G CTLA-4 polymorphism and RA. The G allele frequency was higher in RA patients than HS (46.8 vs 37.7%, OR=1.45, p=0.01). RA patients carrying the A/G genotype were significantly more likely to be positive to CRP and RF. There was no evidence of an association between SNP genotypes and the clinical characteristics of rheumatoid arthritis. Conclusions: The +. 49A>G CTLA-4 polymorphism is a genetic marker of susceptibility for RA in western Mexican population. � 2010 Elsevier B.V.
dc.relationScopus
dc.relationMEDLINE
dc.relationClinica Chimica Acta
dc.relation411
dc.relation09-oct
dc.relation725
dc.relation728
dc.titleThe +49A>G CTLA-4 polymorphism is associated with rheumatoid arthritis in Mexican population
dc.typeArticle


Este ítem pertenece a la siguiente institución